Association between ZFHX3 and PRRX1 Polymorphisms and Atrial Fibrillation Susceptibility from Meta-Analysis.

IF 1.9 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE
International Journal of Hypertension Pub Date : 2021-12-14 eCollection Date: 2021-01-01 DOI:10.1155/2021/9423576
Liting Wu, Min Chu, Wenfang Zhuang
{"title":"Association between ZFHX3 and PRRX1 Polymorphisms and Atrial Fibrillation Susceptibility from Meta-Analysis.","authors":"Liting Wu,&nbsp;Min Chu,&nbsp;Wenfang Zhuang","doi":"10.1155/2021/9423576","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is a common, sustained cardiac arrhythmia. Recent studies have reported an association between ZFHX3/PRRX1 polymorphisms and AF. In this study, a meta-analysis was conducted to confirm these associations. <i>Objective and Methods</i>. The PubMed, Embase, and Wanfang databases were searched, covering all publications before July 20, 2020.</p><p><strong>Results: </strong>Overall, seven articles including 3,674 cases and 8,990 healthy controls for ZFHX3 rs2106261 and 1045 cases and 1407 controls for PRRX1 rs3903239 were included. The odds ratio (OR) (95% confidence interval (CI)) was used to assess the associations. Publication bias was calculated using Egger's and Begg's tests. We found that the ZFHX3 rs2106261 polymorphism increased AF risk in Asians (for example, allelic contrast: OR [95% CI]: 1.39 [1.31-1.47], <i>P</i> < 0.001). Similarly, strong associations were detected through stratified analysis using source of control and genotype methods (for example, allelic contrast: OR [95% CI]: 1.51 [1.38-1.64], <i>P</i> < 0.001 for HB; OR [95% CI]: 1.31 [1.21-1.41], <i>P</i> < 0.001 for PB; OR [95% CI]: 1.55 [1.33-1.80], <i>P</i> < 0.001 for TaqMan; and OR [95% CI]: 1.31 [1.21-1.41], <i>P</i> < 0.001 for high-resolution melt). In contrast, an inverse relationship was observed between the PRRX1 rs3903239 polymorphism and AF risk (C-allele <i>vs.</i> T-allele: OR [95% CI]: 0.83 [0.77-0.99], <i>P</i>=0.036; CT <i>vs.</i> TT: OR [95% CI]: 0.79 [0.67-0.94], <i>P</i>=0.006). No obvious evidence of publication bias was observed.</p><p><strong>Conclusions: </strong>In summary, our study suggests that the ZFHX3 rs2106261 and PRRX1 rs3903239 polymorphisms are associated with AF risk, and larger case-controls must be carried out to confirm the abovementioned conclusions.</p>","PeriodicalId":14132,"journal":{"name":"International Journal of Hypertension","volume":"2021 ","pages":"9423576"},"PeriodicalIF":1.9000,"publicationDate":"2021-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692054/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2021/9423576","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Atrial fibrillation (AF) is a common, sustained cardiac arrhythmia. Recent studies have reported an association between ZFHX3/PRRX1 polymorphisms and AF. In this study, a meta-analysis was conducted to confirm these associations. Objective and Methods. The PubMed, Embase, and Wanfang databases were searched, covering all publications before July 20, 2020.

Results: Overall, seven articles including 3,674 cases and 8,990 healthy controls for ZFHX3 rs2106261 and 1045 cases and 1407 controls for PRRX1 rs3903239 were included. The odds ratio (OR) (95% confidence interval (CI)) was used to assess the associations. Publication bias was calculated using Egger's and Begg's tests. We found that the ZFHX3 rs2106261 polymorphism increased AF risk in Asians (for example, allelic contrast: OR [95% CI]: 1.39 [1.31-1.47], P < 0.001). Similarly, strong associations were detected through stratified analysis using source of control and genotype methods (for example, allelic contrast: OR [95% CI]: 1.51 [1.38-1.64], P < 0.001 for HB; OR [95% CI]: 1.31 [1.21-1.41], P < 0.001 for PB; OR [95% CI]: 1.55 [1.33-1.80], P < 0.001 for TaqMan; and OR [95% CI]: 1.31 [1.21-1.41], P < 0.001 for high-resolution melt). In contrast, an inverse relationship was observed between the PRRX1 rs3903239 polymorphism and AF risk (C-allele vs. T-allele: OR [95% CI]: 0.83 [0.77-0.99], P=0.036; CT vs. TT: OR [95% CI]: 0.79 [0.67-0.94], P=0.006). No obvious evidence of publication bias was observed.

Conclusions: In summary, our study suggests that the ZFHX3 rs2106261 and PRRX1 rs3903239 polymorphisms are associated with AF risk, and larger case-controls must be carried out to confirm the abovementioned conclusions.

Abstract Image

Abstract Image

Abstract Image

ZFHX3和PRRX1基因多态性与房颤易感性的meta分析
背景:心房颤动(AF)是一种常见的持续性心律失常。最近的研究报道了ZFHX3/PRRX1多态性与房颤之间的关联。在本研究中,进行了一项荟萃分析来证实这些关联。目的与方法。检索PubMed、Embase和万方数据库,涵盖2020年7月20日之前的所有出版物。结果:共纳入7篇文献,包括3674例ZFHX3 rs2106261病例和8990例健康对照,1045例PRRX1 rs3903239病例和1407例健康对照。比值比(OR)(95%置信区间(CI))用于评估相关性。使用Egger's和Begg's检验计算发表偏倚。我们发现ZFHX3 rs2106261多态性增加了亚洲人的房颤风险(例如,等位基因对比:OR [95% CI]: 1.39 [1.31-1.47], P < 0.001)。同样,通过使用对照源和基因型方法进行分层分析,发现了强关联(例如,等位基因对比:OR [95% CI]: 1.51 [1.38-1.64], HB的P < 0.001;OR [95% CI]: 1.31 [1.21-1.41], P < 0.001;TaqMan的OR [95% CI]: 1.55 [1.33-1.80], P < 0.001;OR [95% CI]: 1.31[1.21-1.41],高分辨率熔体的P < 0.001)。相比之下,PRRX1 rs3903239多态性与AF风险呈负相关(c等位基因vs t等位基因:OR [95% CI]: 0.83 [0.77-0.99], P=0.036;CT与TT:或[95%可信区间]:0.79 (0.67 - -0.94),P = 0.006)。未观察到明显的发表偏倚证据。结论:综上所述,我们的研究提示ZFHX3 rs2106261和PRRX1 rs3903239多态性与房颤风险相关,必须进行更大规模的病例对照来证实上述结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Hypertension
International Journal of Hypertension Medicine-Internal Medicine
CiteScore
4.00
自引率
5.30%
发文量
45
期刊介绍: International Journal of Hypertension is a peer-reviewed, Open Access journal that provides a forum for clinicians and basic scientists interested in blood pressure regulation and pathophysiology, as well as treatment and prevention of hypertension. The journal publishes original research articles, review articles, and clinical studies on the etiology and risk factors of hypertension, with a special focus on vascular biology, epidemiology, pediatric hypertension, and hypertensive nephropathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信